*Gee Jin Ng¹ (1. National Neuroscience Institute Singapore)

*Putri Nugraheni¹, Attaufiq Irawan ², Almerveldy Azaria Dohong³, Adelina Dwi Putri¹, Ahmad Rafi Faiq⁴ (1. Department of Psychiatry, Pelabuhan Jakarta Hospital, Jakarta, Indonesia, 2. Vila Medika Clinic, South Tangerang, Indonesia., 3. Pembangunan Nasional “Veteran” University, Jakarta, Indonesia, 4. Pondok Indah Bintaro Jaya Hospital, South Tangerang, Indonesia)

*Yukino Ishizaka¹, Akihiro Mouri^1,5, Kazuo Kunisawa¹, Takaya Nishikawa¹, Tomoyuki Furuyashiki², Shuh Narumiya³, Toshitaka Nabeshima^4,5 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Division of Pharmacology, Graduate School of Medicine, Kobe University, Hyogo, Japan., 3. Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., 4. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan., 5. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan.)

*Irma Khachidze¹, Maia Adcadze², N Adamashvili¹ (1. IBCEB, SEU, 2. SEU)

*Nattapon Jaisupa¹, Sofia Birgersson¹, Michael Ashton¹ (1. Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Institute of Neuroscience and Physiology, University of Gothenburg, Sweden)

*Nattapon Jaisupa¹, Michael Ashton¹, Sofia Birgersson¹ (1. Unit for Pharmacokinetic and Drug Metabolism, Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden)